France: BVI takes over Arcadophta

TPG Capital-backed BVI has acquired Arcadophta SARL, better known as Arcad, a Toulouse-based ophthalmic company which specialises in silicon oils, gases and perfluorocarbons used in vitreoretinal surgery. The transaction has closed during the fourth quarter of 2019 and financial terms of the transaction were not disclosed. Arcad was acquired from its founders, who will continue…

You must be a HMI Subscriber to view this content. Please log in or subscribe below.

Subscribe Now »